Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1989-1-26
|
pubmed:abstractText |
Chronic coadministration of oral verapamil with oral atenolol resulted in a variable increase in atenolol steady-state plasma concentrations in a group of 10 patients on chronic maintenance therapy. Individual subjects showed changes in area under the plasma atenolol concentration-time curve (AUC) of more than 100%, however group comparisons did not achieve statistical significance unless normalized for verapamil dose. Renal clearance of atenolol was shown to be decreased by more than 25% in 2 subjects studied using intravenous dosing of atenolol. This interaction is likely to contribute to the documented clinical intolerance of combinations of atenolol and verapamil.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0031-6970
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
363-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3197744-Administration, Oral,
pubmed-meshheading:3197744-Aged,
pubmed-meshheading:3197744-Atenolol,
pubmed-meshheading:3197744-Drug Interactions,
pubmed-meshheading:3197744-Drug Therapy, Combination,
pubmed-meshheading:3197744-Female,
pubmed-meshheading:3197744-Hemodynamics,
pubmed-meshheading:3197744-Humans,
pubmed-meshheading:3197744-Injections, Intravenous,
pubmed-meshheading:3197744-Male,
pubmed-meshheading:3197744-Metabolic Clearance Rate,
pubmed-meshheading:3197744-Middle Aged,
pubmed-meshheading:3197744-Time Factors,
pubmed-meshheading:3197744-Verapamil
|
pubmed:year |
1988
|
pubmed:articleTitle |
Extent and pharmacokinetic mechanisms of oral atenolol-verapamil interaction in man.
|
pubmed:affiliation |
Department of Clinical Pharmacology, Alfred Hospital, Melbourne, Victoria, Australia.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|